Re: Potential use of imatinib in Ewing's sarcoma: evidence for in vitro and in vivo activity

J Natl Cancer Inst. 2003 Jul 16;95(14):1087-8; author reply 1088-9. doi: 10.1093/jnci/95.14.1087-a.
No abstract available

Publication types

  • Comment
  • Letter
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Antineoplastic Agents / pharmacology*
  • Antineoplastic Agents / therapeutic use
  • Benzamides
  • Bone Neoplasms / drug therapy*
  • Bone Neoplasms / metabolism
  • Enzyme Inhibitors / pharmacology*
  • Enzyme Inhibitors / therapeutic use
  • Gene Expression Regulation, Neoplastic
  • Humans
  • Imatinib Mesylate
  • In Vitro Techniques
  • Oncogene Proteins / metabolism*
  • Phosphorylation
  • Piperazines / pharmacology*
  • Piperazines / therapeutic use
  • Precipitin Tests
  • Proto-Oncogene Proteins c-kit
  • Pyrimidines / pharmacology*
  • Pyrimidines / therapeutic use
  • Reverse Transcriptase Polymerase Chain Reaction
  • Sarcoma, Ewing / drug therapy*
  • Sarcoma, Ewing / metabolism

Substances

  • Antineoplastic Agents
  • Benzamides
  • Enzyme Inhibitors
  • Oncogene Proteins
  • Piperazines
  • Pyrimidines
  • Imatinib Mesylate
  • Proto-Oncogene Proteins c-kit